Large Payers, Including CMS, PBMs, Mostly Absent From PCORI Board

With some very overt participation in comparative effectiveness research, one may have expected representatives from traditional large health care organizations or pharmacy benefit managers to be appointed to the Patient-Centered Outcomes Research Institute first board of governors. However, they were left off the board, announced Sept. 23.

More from Archive

More from Pink Sheet